Literature DB >> 22282468

Diurnal plasma concentrations of natriuretic propeptides in healthy young males.

Jens P Goetze, Henrik L Jørgensen, Henriette P Sennels, Jan Fahrenkrug.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282468     DOI: 10.1373/clinchem.2011.178921

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

Review 1.  Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice?

Authors:  Johannes Mair; Allan S Jaffe
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

2.  Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort.

Authors:  Paul Welsh; Ross T Campbell; Leanne Mooney; Dorien M Kimenai; Caroline Hayward; Archie Campbell; David Porteous; Nicholas L Mills; Ninian N Lang; Mark C Petrie; James L Januzzi; John J V McMurray; Naveed Sattar
Journal:  Circ Heart Fail       Date:  2022-09-13       Impact factor: 10.447

3.  Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals.

Authors:  Vibhu Parcha; Nirav Patel; Orlando M Gutierrez; Peng Li; Karen L Gamble; Kiran Musunuru; Kenneth B Margulies; Thomas P Cappola; Thomas J Wang; Garima Arora; Pankaj Arora
Journal:  J Am Coll Cardiol       Date:  2021-05-11       Impact factor: 27.203

4.  Diurnal gene expression of lipolytic natriuretic peptide receptors in white adipose tissue.

Authors:  Julie Smith; Jan Fahrenkrug; Henrik L Jørgensen; Christina Christoffersen; Jens P Goetze
Journal:  Endocr Connect       Date:  2015-08-18       Impact factor: 3.335

5.  Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study.

Authors:  Claudio Sartini; Peter H Whincup; S Goya Wannamethee; Barbara J Jefferis; Lucy Lennon; Gordon DO Lowe; Paul Welsh; Naveed Sattar; Richard W Morris
Journal:  BMJ Open       Date:  2017-11-12       Impact factor: 2.692

6.  Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients.

Authors:  Sandra Crnko; Markella I Printezi; Tijn P J Jansen; Laurynas Leiteris; Manon G van der Meer; Hilde Schutte; Martijn van Faassen; Bastiaan C du Pré; Nicolaas de Jonge; Folkert W Asselbergs; Carlo A J M Gaillard; Hans Kemperman; Pieter A Doevendans; Joost P G Sluijter; Linda W van Laake
Journal:  ESC Heart Fail       Date:  2020-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.